SR ONE CAPITAL MANAGEMENT, LP Long-Term Concentrated

CIK: 0001910264 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 13, 2024

Total Value ($000): $498,735 (100.0% shares, 0.0% debt)

Holdings (11)

ACLX Arcellx, Inc. 39.3%

Value ($000) $195,967 Shares 2,346,630 Est. Cost $16.72 Unrealized +298.3%

ZBIO Zenas BioPharma, Inc 16.7%

Value ($000) $83,103 Shares 4,911,539 Est. Cost $17.98 Unrealized 0.0%

SPRY ARS Pharmaceuticals, Inc. 11.7%

Value ($000) $58,187 Shares 4,012,903 Est. Cost $6.79 Unrealized +75.2%

CRSP CRISPR Therapeutics AG 9.9%

Value ($000) $49,280 Shares 1,048,951 Est. Cost $71.59 Unrealized -29.1%

DSGN Design Therapeutics, Inc. 7.0%

Value ($000) $35,112 Shares 6,526,476 Est. Cost $16.67 Unrealized -71.8%

MLYS Mineralys Therapeutics Inc. 4.9%

Value ($000) $24,424 Shares 2,016,822 Est. Cost $16.34 Unrealized -25.9%

ALMS Alumis Inc. 4.2%

Value ($000) $20,932 Shares 1,959,896 Est. Cost $13.30 Unrealized -8.8%

NKTX Nkarta, Inc. 3.0%

Value ($000) $15,067 Shares 3,333,333 Est. Cost $11.49 Unrealized -50.5%

ORKA Oruka Therapeutics, Inc 1.8%

Value ($000) $9,199 Shares 375,330 Est. Cost $34.79 Unrealized 0.0%

ENGN enGene Holdings Inc. 1.0%

Value ($000) $4,935 Shares 747,750 Est. Cost $11.04 Unrealized -32.6%

KALA KALA Bio, Inc. 0.5%

Value ($000) $2,529 Shares 443,661 Est. Cost $6.61 Unrealized -4.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ACLX	Arcellx, Inc.	2,346,630	$195,967	39.3%	$16.72	+298.3%	Common Stock	03940C100
ZBIO	Zenas BioPharma, Inc	4,911,539	$83,103	16.7%	$17.98	0.0%	Common Stock	98937L105
SPRY	ARS Pharmaceuticals, Inc.	4,012,903	$58,187	11.7%	$6.79	+75.2%	Common Stock	82835W108
CRSP	CRISPR Therapeutics AG	1,048,951	$49,280	9.9%	$71.59	-29.1%	Common Shares	H17182108
DSGN	Design Therapeutics, Inc.	6,526,476	$35,112	7.0%	$16.67	-71.8%	Common Stock	25056L103
MLYS	Mineralys Therapeutics Inc.	2,016,822	$24,424	4.9%	$16.34	-25.9%	Common Stock	603170101
ALMS	Alumis Inc.	1,959,896	$20,932	4.2%	$13.30	-8.8%	Common Stock	022307102
NKTX	Nkarta, Inc.	3,333,333	$15,067	3.0%	$11.49	-50.5%	Common Stock	65487U108
ORKA	Oruka Therapeutics, Inc	375,330	$9,199	1.8%	$34.79	0.0%	Common Stock	687604108
ENGN	enGene Holdings Inc.	747,750	$4,935	1.0%	$11.04	-32.6%	Common Shares	29286M105
KALA	KALA Bio, Inc.	443,661	$2,529	0.5%	$6.61	-4.5%	Common Stock	483119202